EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Intratumoral preservation of the stem-like malignant cell proportion in glioblastoma, prognostic impact, and its radiomethylomic signatures

Yuji Matsumoto, Omkar Singh, Jose Garcia, Zied Abdullaev, Nelson F Freeburg, Fanyang Yu, Hamed Akbari iD, Kyunglok Baik, Jun Guo, Natalie N C Shih, Erik Toorens, Tapan Ganguly und 8 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Yuji Matsumoto und 19 weiteren Autor:innen. Beteiligte Einrichtung: Center for AI and Data Science for Integrated Diagnostics (AI2D), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania…. Hauptthemen laut MEDLINE: Glioblastoma, DNA Methylation, Brain Neoplasms, Neoplastic Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH, NINDS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GBM) exhibits significant intratumoral heterogeneity. However, the presence and extent of intratumoral heterogeneity of stem-like and differentiated cell components based on methylation profiles remain poorly understood. Furthermore, the utility of integrating methylation profiles with radiomic features (radiomethylomics) for predicting these cellular states has not been explored.

Methods

We analyzed 248 samples from 133 GBM patients, including 157 samples from 42 patients whose tumors were sampled at multiple points. Two distinct methylation-based deconvolution analyses were performed to assess cellular composition. Radiomethylomic models were developed using support vector machines with features extracted from multi-parametric MRI.

Results

Multi-sampling analysis revealed that the proportion of stem-like cells among total malignant cells was homogeneously preserved within tumors. Tumors harboring a higher proportion of stem-like cells (stem-like tumors) showed significantly shorter overall survival and diminished benefits from O6-methylguanine DNA methyltransferase (MGMT) promoter methylation. Stem-like tumors showed a strong correlation with the RTK I subtype. Integrating physiological MRI features (diffusion tensor imaging and dynamic susceptibility contrast) with conventional sequences enhanced the performance of radiomethylomic models for predicting stem-like tumor status and prognostic stratification.

Conclusions

Our findings reveal a homogeneous preservation of the proportion of stem-like cells over total malignant cells within GBM, establishing its significance as a tumor-wide feature. The development of radiomethylomic signatures shows potential for noninvasive assessment of tumor stemness, ultimately facilitating personalized treatment strategies in light of the prognostic impact of the feature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaDNA MethylationBrain NeoplasmsNeoplastic Stem CellsBiomarkers, TumorHumansPrognosisMaleFemaleMiddle AgedMagnetic Resonance ImagingDNA Repair EnzymesSurvival RateAgedDNA Modification MethylasesAdultFollow-Up StudiesTumor Suppressor Proteins

Stichwörter der Autor:innen

DNA methylationglioblastomaheterogeneityradiomicsstem-like cells

Substanzen

MGMT protein, humanDNA Repair EnzymesBiomarkers, TumorDNA Modification MethylasesTumor Suppressor Proteins

Autor:innen und Institutionen

  • Center for AI and Data Science for Integrated Diagnostics (AI2D), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Bioengineering, School of Engineering, Santa Clara University, Santa Clara, California, USA.
  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Penn Genomic Analysis Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Hamed Akbari, Kenneth Aldape, Christos Davatzikos, MacLean P Nasrallah

Förderung

  • NIH
  • NINDS NIH HHS
  • NCI NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • NCI

Zitieren

APA

Matsumoto, Y., Singh, O., Garcia, J., Abdullaev, Z., Freeburg, N. F., Yu, F., Akbari, H., Baik, K., Guo, J., Shih, N. N. C., Toorens, E., Ganguly, T., Ballinger, D., O'Rourke, D. M., Mohan, S., Morrissette, J. J. D., Silverbush, D., Aldape, K., Davatzikos, C., & Nasrallah, M. P. (2025). Intratumoral preservation of the stem-like malignant cell proportion in glioblastoma, prognostic impact, and its radiomethylomic signatures. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf175

Vancouver

Matsumoto Y, Singh O, Garcia J, Abdullaev Z, Freeburg NF, Yu F, et al. Intratumoral preservation of the stem-like malignant cell proportion in glioblastoma, prognostic impact, and its radiomethylomic signatures. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf175

BibTeX
@article{Matsumoto2025,
  author = {Matsumoto, Yuji and Singh, Omkar and Garcia, Jose and Abdullaev, Zied and Freeburg, Nelson F and Yu, Fanyang and Akbari, Hamed and Baik, Kyunglok and Guo, Jun and Shih, Natalie N C and Toorens, Erik and Ganguly, Tapan and Ballinger, Dominique and O'Rourke, Donald M and Mohan, Suyash and Morrissette, Jennifer J D and Silverbush, Dana and Aldape, Kenneth and Davatzikos, Christos and Nasrallah, MacLean P},
  title = {Intratumoral preservation of the stem-like malignant cell proportion in glioblastoma, prognostic impact, and its radiomethylomic signatures},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf175}
}
Kostenlos starten →